{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreieoeciw3xujholcyfztvwg56m2ffrkiaihz7bwv4x76xqavwdozku",
    "uri": "at://did:plc:izotgtw5czjnuqtpcldjnkjh/app.bsky.feed.post/3mly7unms4ob2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreida5gte2fo6bxtbliyajxrbzacl4iwmej4nspbsqpz4pnn2dtgwru"
    },
    "mimeType": "image/jpeg",
    "size": 279187
  },
  "path": "/scientists-uncover-cancer-fighting-power-of-popular-fatty-liver-drug/",
  "publishedAt": "2026-05-16T16:01:49.000Z",
  "site": "https://scitechdaily.com",
  "tags": [
    "Health",
    "Cancer",
    "Immunotherapy",
    "Liver",
    "Oncology",
    "The University of Hong Kong"
  ],
  "textContent": "A new study suggests that Resmetirom may do more than treat fatty liver disease — it could also help stop liver cancer from developing. Resmetirom, a drug approved by the U.S. Food and Drug Administration (FDA) to treat metabolic dysfunction associated fatty liver disease (MAFLD), may offer benefits beyond reducing liver fat and fibrosis, according [...]",
  "title": "Scientists Uncover Cancer-Fighting Power of Popular Fatty Liver Drug"
}